Mesa Laboratories
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $59,543 | $62,135 | $62,840 | $57,833 |
Gross Profit | 32,494 | 38,412 | 39,754 | 35,455 |
EBITDA | 15,167 | 10,477 | 6,122 | 12,898 |
EBIT | 9,210 | 2,980 | 625 | 6,830 |
Net Income | 4,742 | -7,114 | -1,676 | 3,428 |
Net Change In Cash | 59,543 | 62,135 | 62,840 | 57,833 |
Free Cash Flow | 884 | 11,658 | 17,626 | 3,483 |
Cash | 21,279 | 27,321 | 30,956 | 24,337 |
Basic Shares | 5,553 | 5,429 | 5,429 | 5,471 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $240,978 | $216,187 | $219,080 | $184,335 |
Gross Profit | 150,870 | 133,250 | 133,693 | 109,090 |
EBITDA | 42,347 | -238,377 | 36,454 | 29,770 |
EBIT | 17,820 | -269,951 | 3,320 | 4,702 |
Net Income | -1,974 | -254,246 | 930 | 1,871 |
Net Change In Cash | 240,978 | 216,187 | 219,080 | 184,335 |
Cost of Revenue | -14,839 | |||
Free Cash Flow | 42,309 | 41,566 | 23,439 | 34,791 |
Cash | 27,321 | 28,214 | 32,910 | 49,346 |
Basic Shares | 5,429 | 5,386 | 5,361 | 5,335 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $1.88 |
2025-03-31 | $2.25 |
2024-12-31 | $0.79 |
